Sera from residual specimens from NHANES 2001-2002 participants were tested for levels of human epididymal secretory protein E4 (HE4). The results for HE4 in this data release are reported as pM.
Female participants age 20+ who consented to storing their samples for future research and had stored samples from 2001-2002.
All measurements were performed in the Genital Tract Biology Laboratory (Brigham and Women’s Hospital, Lab Director Fichorova) following pre-analytic, analytic, and post-analytic standardized operational procedures (SOPs) established under the Laboratory Director and special chemistry accreditation by the College of American Pathologists. The lab used the Meso Scale Discovery (MSD) (Gaithersburg, MD) electrochemiluminescence immunoassay platform. Quality control (QC) pools were prepared and split into multiple aliquots. To establish inter-and intra-plate variability, one aliquot of this pool was repeatedly tested on each assay plate. A coefficient of variation of < 25% was set as a threshold for acceptance of the data.
In further detail, the following assays and methodology were applied:
Human Prototype HE4 (96-well prototype plate 4 spot, catalog number N45YA-1)
The linearity range for the HE4 was 3600–0.55 pM (lowest limit of detection (LLD) 0.006 pM). All samples were tested undiluted and 47 samples were repeatedly tested to verify values <1 and >99 percentile. One plate was repeated due to systematically lower/outlier values. Three QC samples were used spanning three logs of the assay range: 1) a plasma pool prepared by pooling a small volume (5 ul/ sample) from over 2000 serum samples which had shown measurable HE4 levels in a prior study using the MSD platform1,2; 2) a QC generated from a standard of known HE4 concentration; 3) a plasma pool prepared by pooling samples obtained from a cohort of ovarian cancer cases.
The unblinded quality control sample pool repeatedly tested on every assay plate showed the following inter-plate CV and min–max range (mean) of intraplate CV of the three QCs tested: (i) QC #1, 18.3% inter-plate CV and 0.2%–9.2% (2.9%) intraplate CV; (ii) QC #2: 21.25% inter-plate CV and 0.2%–14.4% (3.3%) intraplate CV; and iii) QC #3: 15.04% inter-plate CV and 0.3%–12.3% (3.1%) intraplate CV.
The acceptable QC pool variation was set to 25%. Back fit analysis of each calibrator was also set to 25% acceptable level. Outliers were confirmed by repeated testing and samples outside the linearity range of each assay were repeatedly tested at adjusted dilution to produce acceptable value.
Data was compiled into a database after all the assays were completed and passed quality control criteria. The data were not edited.
Data Access: All data will be made publicly available.
Results were measured as pM.
|Code or Value||Value Description||Count||Cumulative||Skip to Item|
|0.1 to 466.9||Range of Values||2522||2522|